{"id":"NCT00299130","sponsor":"Genentech, Inc.","briefTitle":"A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis","officialTitle":"A Randomized, Placebo Controlled, Double-blind, Parallel Group, International Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate, Compared to Methotrexate Monotherapy, in Patients With Active Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-10","primaryCompletion":"2008-06","completion":"2013-07","firstPosted":"2006-03-06","resultsPosted":"2013-06-28","lastUpdate":"2017-04-17"},"enrollment":511,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Folate","otherNames":[]},{"type":"DRUG","name":"Methotrexate","otherNames":[]},{"type":"DRUG","name":"Methylprednisolone","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Rituximab","otherNames":["MabThera®","Rituxan®"]}],"arms":[{"label":"Placebo + methotrexate (MTX)","type":"ACTIVE_COMPARATOR"},{"label":"Rituximab 2 x 0.5 g + MTX","type":"EXPERIMENTAL"},{"label":"Rituximab 2 x 1.0 g + MTX","type":"EXPERIMENTAL"}],"summary":"This study evaluated the efficacy and safety of rituximab in patients with active rheumatoid arthritis (RA).","primaryOutcome":{"measure":"Percentage of Participants With American College of Rheumatology (ACR) 20 Response at Week 24","timeFrame":"Baseline and Week 24","effectByArm":[{"arm":"Placebo + MTX","deltaMin":23.3,"sd":null},{"arm":"Rituximab 2 x 0.5 g + MTX","deltaMin":54.5,"sd":null},{"arm":"Rituximab 2 x 1.0 g + MTX","deltaMin":50.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20488885","22127691"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":172},"commonTop":["Infusion related reaction","Upper respiratory tract infection","Rheumatoid arthritis","Nasopharyngitis","Urinary tract infection"]}}